JNM Global

Global Approval Partner

jnmKorea 1424

MDSAP, MDSAP AUDIT APPROACH Amendment (MDSAP APP0002.009) Announced

The FDA published a revised MDSAP AUDIT APPROACH (MDSAP AU P0002.009) on August 6, 2024.The revision from MDSAP AU P0002.008 to 009 is briefly as follows. 1. Australia (TGA)As a result of changes to the Guidance for Australia (TGA) country-specific requirements, the following items have been revised or removed from the TGA requirements.1) Management - Task 5 & Task 82) Device Marketing Authoriza..

China NMPA, Announcement of No. 84 [2024] to clarify requirements for high frequency treatment devices

The National Medical Products Administration (NMPA) of China issued the Regulations on July 8, 2024 to steadily promote the relevant work of high-frequency treatment devices and high-frequency skin treatment devices, and take into account the requirements of public equipment safety and orderly development of the industry. Annex 09-07-02 of the “Notice on Partial Adjustment of the Medical Device ..

Australia TGA, updates distribution record keeping and storage

The Australian Therapeutic Goods Administration (TGA) has updated its medical device distribution record requirements from 23 May 2024. Under section 41FO of the Treatment Supplies Act 1989, sponsors of medical devices supplied and exported from Australia must keep the following distribution record.Expedite any recalls of the medical devices.Identify the manufacturer of each batch of devices.Rec..

Australia TGA, Announces Revised Sunscreen Requirements Through 2024 Measures No. 2

In Australia, sunscreen is classified as a primary sunscreen or a secondary sunscreen depending on the SPF index. If it is classified as a medical product according to the performance of sunscreen, it is subject to TGA regulation, and if it is classified as a cosmetic, it is subject to AICIS regulation. Australia's Therapeutic Goods Administration (TGA) has announced updated requirements for sun..

JNM Global/Cosmetic 2024.07.18

Singapore HAS, Announcement of increase in medical device registration fee

Singapore HSA(Health Sciences Authority) applies Review Fee Increase Effective July 1, 2024. With effect from 1 July 2024, a fee increase averaging 5% will be implemented, with a minimum increase of $1 and capped at $200 per fee item. The increased medical device fees are briefly as follows.1.     Medical Device RegistrationProduct registration and evaluation feeClass BClass CClass DClass D with..

Thailand TFDA, Announcement of Guidelines for Software as a Medical Device (SaMD) Registration

Thailand's Food and Drug Administration (TFDA) has issued guidelines on May 9, 2024 for registration of software (SaMD) to determine whether SaMD software is suitable as a medical device. The guidelines for Software as a Medical Device (SaMD) registration are briefly as follows.  Type of medical device software >-       Embedded Software: Software embedded in medical devices-       Standalone So..

Korea MFDS, Announcement of revised medical device Adverse Event report guidelines

On May 27, 2024, the Ministry of Food and Drug Safety (MFDS) posted a revised version of the "Medical Device Adverse Event Report Guidelines" reflecting the revision of the standard code for medical device abnormalities and the frequently used standard code case. The medical device safety information management system is briefly as follows.1. If the medical device handler recognizes that death o..

Singapore HSA, Issuing guidelines for submission of medical device registration documents for in vitro diagnostics

HAS Medical device product registration applications,  specifically for in vitro diagnostic devices, should be submitted online through MEDICS, utilizing the CSDT or IMDRF IVD MA ToC.In this regard, the Singapore HSA(Health Sciences Authority) issued a directive document on the submission of product registration on March 1, 2024.It details the process for uploading documents related to either th..

Indonesia MoH, Announcement of the Implementation of CDAKB(GOOD DISTRIBUTION PRACTICE REQUIREMENTS) Certificate as a Requirement for Marketing Authorization

On May 16, 2024, the Indonesia Ministry of Health issued an Announcement Number FR.03.01/E/884/2024 about the Implementation of the CDAKB Certificate (Good Distribution Practice of Medical Devices) as a Requirement for Marketing Authorization. The Ministry of Health (MoH) is providing a transition period from May 1st to June 30th, 2024. Therefore, Local Distributors and License Holders must have..

Philippines PFDA, FDA Circular No.2024-003_CMDN deadline extended to 2024 following amendments to An-nex A of FDA Circular No. 2020-001

Philippine FDA announced FDA Circular No.2024-003 on March 26, 2024. This issuance extended the dates for the application of a CMDN and CMDR for all Class B, C and D medical device that are not included in the list of registrable medical devices based on FC No. 2020-001-A. All Class B, C and D medical devices that are not included in the list of registrable medical devices based on FC No. 2020-0..